Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 941 | 450 | 742 | 433 | 6,209 |
| Depreciation Amortization | 523 | 405 | 270 | 130 | 438 |
| Income taxes - deferred | 471 | 266 | 440 | 257 | -5,156 |
| Accounts receivable | -1,851 | 431 | 783 | -713 | 953 |
| Other Working Capital | -1,521 | -409 | 154 | -901 | 593 |
| Other Operating Activity | 2,197 | -190 | -603 | 943 | -769 |
| Operating Cash Flow | $761 | $952 | $1,785 | $149 | $2,268 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -872 | -715 | -448 | -224 | -727 |
| Investing Cash Flow | $-872 | $-715 | $-448 | $-224 | $-727 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -68 | -56 | -44 | -25 | -955 |
| Common Stock Issued | 120 | 99 | 85 | 43 | 288 |
| Financing Cash Flow | $52 | $43 | $41 | $18 | $-667 |
| Beginning Cash Position | 3,011 | 3,011 | 3,011 | 3,011 | 2,136 |
| End Cash Position | 2,952 | 3,291 | 4,390 | 2,954 | 3,011 |
| Net Cash Flow | $-59 | $280 | $1,379 | $-57 | $875 |
| Free Cash Flow | |||||
| Operating Cash Flow | 761 | 952 | 1,785 | 149 | 2,268 |
| Capital Expenditure | -872 | -715 | -448 | -224 | -727 |
| Free Cash Flow | -111 | 237 | 1,338 | -75 | 1,542 |